(Q36317981)

13 August 2017

1 reference

title

F2-isoprostanes as markers of oxidative stress in vivo: an overview (English)

1 reference

13 August 2017

0 references

Ginger L Milne

1

1 reference

13 August 2017

Erik S Musiek

series ordinal

2

1 reference

13 August 2017

Jason D Morrow

series ordinal

3

1 reference

13 August 2017

publication date

1 November 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

10 Suppl 1

1 reference

13 August 2017

page(s)

S10-23

1 reference

Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Factors associated with oxidative stress in human populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Determination of isoprostanes in urine samples from Alzheimer patients using porous graphitic carbon liquid chromatography–tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Determinants of F2-isoprostane biosynthesis and inhibition in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Platelet activation in obese women: role of inflammation and oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Urinary excretion of 8-iso-PGF(2 alpha) in three patients during sepsis, recovery and state of health

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

The isoprostanes: unique products of arachidonic acid oxidation-a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Plasma levels of 8-epiPGF2alpha, an in vivo marker of oxidative stress, are not affected by aging or Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Years of life lost due to obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Obesity, metabolic syndrome, and coronary atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

The measurement of free radical reactions in humans. Some thoughts for future experimentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Increased CSF F2-isoprostane concentration in probable AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F(2t)-Isoprostane (8-iso-PGF(2alpha)) by a stable isotope dilution mass spectrometric assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

The isoprostanes: unique bioactive products of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Overweight, obesity, and health risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

IPF2alpha-I: an index of lipid peroxidation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Localization of distinct F2-isoprostanes in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Measurement of F(2)-isoprostanes unveils profound oxidative stress in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

The isoprostanes: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Isoprostane 8-epi-PGF2alpha is frequently increased in patients with muscle pain and/or CK-elevation after HMG-Co-enzyme-A-reductase inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

A nomenclature system for the isoprostanes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

Increased F2Isoprostanes in the Acute Chest Syndrome of Sickle Cell Disease as a Marker of Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216546

10.1080/13547500500216546

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference